Hepatic Encephalopathy

What Is Hepatic Encephalopathy?

Hepatic encephalopathy (HE) is a neuropsychiatric syndrome that occurs in people with liver dysfunction, most commonly advanced cirrhosis. The condition ranges from subtle cognitive changes to deep coma. It results from the livers inability to detoxify substancesparticularly ammonialeading to their accumulation in the bloodstream and subsequent effects on the brain.

Pathophysiology

Several mechanisms contribute to HE:

• Ammonia accumulation: Impaired urea cycle conversion of ammonia to urea allows ammonia to cross the bloodbrain barrier.
• Neuroinflammation: Circulating inflammatory cytokines sensitize the brain to toxins.
• Altered neurotransmission: Imbalance of excitatory (glutamate) and inhibitory (GABA) pathways.
• Changes in cerebral energy metabolism: Mitochondrial dysfunction reduces ATP production.

Types of Hepatic Encephalopathy

HE is classified according to onset, precipitating factors, and severity:

By Onset

• Acute: Sudden development, often after a precipitating event.
• Chronic: Persistent or recurrent symptoms over months to years.

By Precipitating Factors

• Infections
• Gastrointestinal bleeding
• Electrolyte disturbances (e.g., hyponatremia)
• Renal impairment
• Medications (e.g., sedatives, narcotics)
• Constipation

By Severity (West Haven Criteria)

• Grade 0 Minimal (no obvious clinical signs, detectable only by tests)
• Grade I Changes in personality, mild confusion, euphoria or irritability
• Grade II Lethargy, disorientation, asterixis
• Grade III Somnolence, gross disorientation, marked asterixis
• Grade IV Coma

Clinical Presentation

Symptoms vary with grade:

• Difficulty concentrating or performing simple tasks.
• Personality changes, mood swings, or depression.
• Sleepwake cycle disturbances.
• Asterixis (flapping tremor) of the hands.
• Slurred speech, asterixis of the tongue.
• Progressive confusion leading to stupor or coma in severe cases.

Diagnostic Approach

Diagnosis is clinical, supported by investigations:

• Neuropsychological testing: Number Connection Test, PHES (Psychometric Hepatic Encephalopathy Score) for minimal HE.
• Blood tests: Elevated ammonia levels, though not always proportional to severity.
• Liver function tests: Bilirubin, INR, albumin.
• Imaging: Ultrasound, CT or MRI to rule out alternative causes (e.g., intracranial pathology).
• Electroencephalogram (EEG): Diffuse slowing typical in HE.

Management

Identify and Treat Precipitating Factors

Prompt correction of infections, GI bleeding, electrolyte abnormalities, and constipation is essential.

NonAbsorbable Disaccharides

Lactulose is the firstline therapy. It acidifies the colon, converting ammonia (NH) to ammonium (NH), which is trapped and eliminated. Typical dosing: 25mL (20g) orally three to four times daily, titrated to produce 23 soft stools per day.

Antibiotics

Rifaximin (550mg twice daily) reduces ammoniaproducing gut bacteria and is used alone or in combination with lactulose for recurrent HE.

Nutritional Strategies

• Protein restriction is no longer recommended; adequate protein (1.21.5g/kg/day) supports muscle mass, which helps ammonia clearance.
• Lateevening carbohydrate snacks to prevent catabolism.
• Branchedchain amino acid supplements in selected patients.

Other Therapies

• Probiotics and prebiotics (e.g., lactobacillus preparations) modest benefit.
• Vinylcysteine (sodium benzoate) used rarely.
• Emerging agents: glycerol phenylbutyrate, Lornithine Laspartate.

Prevention of Recurrence

Longterm lactulose (maintenance dose) plus rifaximin is the most effective regimen for preventing recurrent episodes. Regular monitoring for medication compliance, electrolyte balance, and renal function is recommended.

Prognosis

HE significantly impacts quality of life and is a predictor of mortality in cirrhosis. Early recognition and treatment improve outcomes, but repeated episodes reflect progressive liver disease and often precede liver transplantation.

When to Consider Liver Transplantation

Patients with refractory HE despite optimal medical therapy, especially when combined with other complications of decompensated cirrhosis (e.g., variceal bleeding, ascites), should be evaluated for transplant listing.

Key Takeaways

• HE is a reversible brain dysfunction caused by liver failure; prompt treatment can restore cognition.
• Always search for precipitating factorstreating the trigger is as important as medications.
• Lactulose plus rifaximin is the cornerstone of both acute management and longterm prevention.
• Maintaining nutrition and avoiding unnecessary protein restriction supports recovery.
• Recurrent encephalopathy signals advanced disease and warrants transplant assessment.

For further reading, see the American Association for the Study of Liver Diseases (AASLD) guidelines and the European Association for the Study of the Liver (EASL) clinical practice recommendations.